Trials / Unknown
UnknownNCT02002962
Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter
Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter to Prevent Post-procedural Atrial Fibrillation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized study was to assess the effectiveness of endomyocardial botulinum toxin injection for preventing post-procedural atrial fibrillation in patients undergoing the radiofrequency ablation of atrial flutter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | radiofrequency ablation | |
| DRUG | Botulinum Toxin Type A injection |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2015-06-01
- Completion
- 2016-01-01
- First posted
- 2013-12-06
- Last updated
- 2015-09-23
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02002962. Inclusion in this directory is not an endorsement.